Cholesterol levels predict if under-45s will ever have heart disease

An analysis of nearly 400,000 people suggests that the cholesterol levels of young adults can predict whether they ’ll develop cardiovascular disease in later life
Source: New Scientist - Health - Category: Consumer Health News Source Type: research

Related Links:

BOSTON (CBS) — Marijuana use is growing in popularity and local doctors are sounding the alarm about the potential harms the drug could have on the heart. They say marijuana carries many of the same cardiovascular risks as smoking tobacco. Researchers at Brigham and Women’s Hospital say while more patients are curbing their use of cigarettes, there has been an acceleration in marijuana use that marijuana users are now exceeding cigarette smokers. And the effects of the drug on cardiovascular health are not fully understood. Some studies have linked marijuana use with stroke, arrhythmias, and other heart conditi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall Marijuana Source Type: news
(Natural News) We’ve all had it drilled into our heads that high cholesterol is bad and bringing it down with statins can prevent a heart attack. However, that doesn’t explain why many people who take statins still end up developing cardiovascular disease. A recent study shows that there’s far more to the cardiovascular disease equation...
Source: - Category: Consumer Health News Source Type: news
BEST supplements for cholesterol: Having high levels of cholesterol in your blood can lead to heart disease so it is important to keep high cholesterol at bay. Making even small lifestyle tweaks can help to lower cholesterol, and to that end, including a plant-based supplement in your diet may help keep the harmful substance in check.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Publication date: Available online 13 January 2020Source: Medical Journal Armed Forces IndiaAuthor(s): Rajvir BhalwarAbstractMetabolic Syndrome (MetS) is a clustering of specific risk factors, namely, central obesity, raised blood pressure, impaired fasting glucose, raised triglycerides, and low levels of high-density lipoprotein-cholesterol (HDL-C). This constellation is triggered by insulin resistance and its resultant hyperinsulinemia. The two most important and universally agreed causes of insulin resistance are increased body fat (particularly central obesity) and physical inactivity. Other causes include certain gene...
Source: Medical Journal Armed Forces India - Category: General Medicine Source Type: research
The University of Kentucky conducted a study in which Appalachian Kentucky participants took part in a self-care course and focused on reducing risk factors for heart disease, such as weight, cholesterol, or blood pressure. During the process, researchers learned from the residents and adapted their program to fit the cultural needs of the area.
Source: News stories via the Rural Assistance Center - Category: Rural Health Source Type: news
Thousands of lives could be saved by a new heart disease drug, experts say.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
Mass trial of drug inclisiran comes after health service strikes deal with NovartisThe NHS is to launch a mass trial of an as-yet unapproved twice-yearly cholesterol-lowering injection, which it hopes will save lives and cut medical bills for thousands of people who do not take statins.About 40,000 people with high “bad” or low-density lipoprotein cholesterol will be invited to join the trial of inclisiran by NHS England via their GPs. The NHS has struck a novel deal with drugmaker Novartis, which will provide the injections free in exchange for the results of the five-year trial, which will be run by the NHS s...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Heart disease NHS Society Health Statins Drugs Science Novartis UK news Pharmaceuticals industry Source Type: news
ConclusionsNeither baseline HDLP nor the change in HDLP on treatment with dalcetrapib or placebo was associated with risk of MACE after ACS.
Source: American Heart Journal - Category: Cardiology Source Type: research
CONCLUSIONS: Considering the formation of saturated fatty acids, statin performed better in males. With Omega-3 polyunsaturated fatty acids involved, changes in lipoproteins, cholesterol and fatty acids (liver and myocardium) were similar to those caused by small doses of a statin drug. Effects from the combination of bisoprolol and acetylsalicylic acid were completely different from those caused by the use of statin. PMID: 31916523 [PubMed - as supplied by publisher]
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research
AbstractBecause the phenomenon of no reflow has a poor prognosis in ST-segment elevation myocardial infarction (STEMI) patients and the atherogenic index of plasma (AIP) has been shown to be a strong predictor of coronary heart disease, we aimed to investigate the relationship between AIP and no-reflow in patients with acute STEMI who underwent primary percutaneous coronary intervention (PCI). A total of 763 consecutive STEMI patients (648 men; mean age 58  ± 12 years) who underwent primary PCI were recruited for this study. The patients were classified into a reflow group (n = 537) ...
Source: The International Journal of Cardiovascular Imaging - Category: Radiology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Health | Heart | Heart Disease